Cargando…
Long-term quality of life in cervical dystonia after treatment with abobotulinum toxin A: a 2-year prospective study
BACKGROUND: The short-term quality of life (QoL) in cervical dystonia (CD) after treating with abobotulinum toxin A (Abo-BTX A) and neubotulinum toxin A (Neu-BTX A) have been studied in Thai CD patients. However; the long-term study has not been published. OBJECTIVE: The aim of the present study was...
Autores principales: | Kongsaengdao, Subsai, Maneeton, Narong, Maneeton, Benchalak |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5927345/ https://www.ncbi.nlm.nih.gov/pubmed/29731634 http://dx.doi.org/10.2147/NDT.S152252 |
Ejemplares similares
-
Quality of life in cervical dystonia after treatment with botulinum toxin A: a 24-week prospective study
por: Kongsaengdao, Subsai, et al.
Publicado: (2017) -
Low-Dose Neubotulinum Toxin A versus Low-Dose Abobotulinum Toxin A Injection for the Treatment of Cervical Dystonia: A Multicenter, 48-Week, Prospective, Double-Blinded, Randomized Crossover Design Study
por: Kongsaengdao, Subsai, et al.
Publicado: (2021) -
The Five-Year Prospective Study of Quality of Life in Hemifacial Spasm Treated with Abo-Botulinum Toxin A
por: Kongsaengdao, Subsai, et al.
Publicado: (2021) -
Effectiveness of Favipiravir monotherapy in the treatment of COVID-19: real world data analysis from Thailand
por: Srisubat, Attasit, et al.
Publicado: (2023) -
Melatonin Receptor Agonists for the Prevention of Delirium: An Updated Systematic Review and Meta-Analysis of Randomized Controlled Trials
por: Maneeton, Benchalak, et al.
Publicado: (2022)